401(k) · DOL Form 5500 · 2022

Leidos Biomedical Research, Inc. 401(k) Plan

Data updated 2026-08-11

$239M
Total assets
2,203
Participants
96th
Percentile by assets
$108,274
Avg per participant
PlainRetire home → About this data

Official DOL plan name: Leidos Biomedical Research, Inc. Capital Accumulation Plan · Sponsored by Leidos Biomedical Research, Inc. · Maryland · Professional & Technical Services

$239M in assets, 2,203 participants

Leidos Biomedical Research, Inc.'s Leidos Biomedical Research, Inc. Capital Accumulation Plan reported $239M in total assets and 2,203 participants in its 2022 DOL Form 5500 filing, ranking in the 96th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

  • 96th percentile by assets (of 139,126 plans)
  • #20,965 in Professional & Technical Services (21,562 peers)

Coverage in Maryland

Leidos Biomedical Research, Inc. Capital Accumulation Plan covers 2,203 participants in Maryland, 2.4x the typical Maryland plan (state average ~929 per filing). Assets: $239M.

$239M
total plan assets (2022 EOY)
2,203
covered participants
96th
percentile by assets (of 139,126 plans)
$108,274
avg assets per participant

The plan reported a net loss of $26M for the year, a single-year figure driven by markets and benefit payments, not a measure of plan health.

Participants vs Maryland filers

In Maryland, the average filing covers about 929 participants across 2,484 plans. Leidos Biomedical Research, Inc. Capital Accumulation Plan reports 2,203 participants - 2.4x that state average ($239M EOY assets).

Maryland filing particulars

Total Assets (Beginning of Year)$265M
Net Assets (End of Year)$239M
Net Income-$26M
Employer EIN330653185
Plan Effective Date2006-07-01
Filing StatusFILING RECEIVED

Sponsor Plan History (Leidos Biomedical Research, Inc.)

$600M$700M$800M$900M 202220232024 $670M $848M ▲ +26.6%
Total plan assets by year, all Leidos Biomedical Research, Inc. plans on file
Year Plans Participants Total Assets
2022 3 3,261 $670M
2023 3 3,287 $776M
2024 3 3,360 $848M

Nearby 401(k) Plans in Maryland

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Leidos Biomedical Research, Inc. Capital Accumulation Plan vs. nearby 401(k) plans in Maryland, assets vs. participants

Leidos Biomedical Research, Inc. Capital Accumulation Plan vs. nearby 401(k) plans in Maryland, assets vs. participants Scatter plot of 6 data points. -20000020000400006000080000100000 -1001020304050 Total assets ($B) Participants Leidos Biomedical Re…Lockheed Martin Corp…Marriott Retirement …T. Rowe Price U.S. R…Nfl Player Second Ca…Sodexo 401 (K) Emplo…
Leidos Biomedical Research, Inc. Capital Accumulation Plan vs. nearby 401(k) plans in Maryland, assets vs. participants

Similar-Sized 401(k) Plans Nationally

401(k) plans in other states closest to Leidos Biomedical Research, Inc. Capital Accumulation Plan by total assets, not by location.

Frequently Asked Questions

How did Leidos Biomedical Research, Inc. Capital Accumulation Plan assets move in 2022?
Leidos Biomedical Research, Inc. Capital Accumulation Plan pulled back noticeably - down 9.9% during 2022, from $265M to $239M. Reported net income was -$26M.
How have Leidos Biomedical Research, Inc. plan assets changed over time?
Across 3 plan years on file (2022-2024), Leidos Biomedical Research, Inc.'s sponsor-wide assets grew 26.6%, from $670M to $848M.
Where does Leidos Biomedical Research, Inc. Capital Accumulation Plan rank by assets among Form 5500 filers?
Leidos Biomedical Research, Inc. Capital Accumulation Plan ranks in the 96th percentile by end-of-year assets among 139,126 plans that reported assets for plan year 2022 (in the top 5% of all filed plans by assets).
Which 401(k) plans are similar in size to Leidos Biomedical Research, Inc. Capital Accumulation Plan?
Among 401(k) plans in other states, the closest by assets is Awg, Inc Restated 401(k) Plan in KS ($239M, 2,239 participants).

Next read for Leidos Biomedical Research, Inc. Capital…

Filing takeaways

Ways to act on Leidos Biomedical Research, Inc. Capital Accumulation Plan's numbers.